Printer Friendly

CYTRX CORPORATION ANNOUNCES APPOINTMENT OF NEW VICE PRESIDENT

 CYTRX CORPORATION ANNOUNCES APPOINTMENT OF NEW VICE PRESIDENT
 NORCROSS, Ga., April 22 /PRNewswire/ -- CytRx Corporation (NASDAQ-NMS: CYTR) is pleased to announce the appointment of Lucine E. Beauchard as vice president, Business Development/Marketing for the CytRx Corporation.
 Beauchard will also become a corporate officer of the company.
 As vice president, Business Development/Marketing, Beauchard will be responsible for all licensing activities, marketing activities surrounding new products to include market research, pre-marketing activities and commercial evaluation of new technologies. She will also be responsible for the supervision of the TiterMax(TM) brand sales and marketing activities as well as corporate communications with analysts and the investment community.
 Prior to joining CytRx, Beauchard's experience included business development and marketing positions at McNeil Pharmaceutical, a division of Johnson and Johnson, and at Rhone-Poulenc Rorer as well as marketing consulting services for biomedical companies at the firm of Barton and Pittinos.
 CytRx Corporation is a biopharmaceutical company engaged in the research and development of therapeutics incorporating copolymers. The company is developing human pharmaceutical products intended for use in the treatment of vascular, immune system and infectious diseases as well as burns. The company is also developing feed additives intended for growth enhancement in food animals, adjuvants for use in both human and veterinary vaccines and is currently marketing Hunter's TiterMax(TM) an immunoadjuvant for use by the basic research community.
 -0- 4/22/92
 /CONTACT: CytRx Corporation public relations, 404-368-9500/
 (CYTR) CO: CytRx Corporation ST: Georgia IN: MTC SU: PER


BR-EA -- AT005 -- 1134 04/22/92 10:04 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 22, 1992
Words:255
Previous Article:KUHLMAN REPORTS RECORD QUARTERLY EARNINGS
Next Article:PATRICK PETROLEUM COMPANY REPORTS SUCCESSFUL DEEP GAS WELL IN MICHIGAN


Related Articles
CYTRX CORPORATION ANNOUNCES APPOINTMENT OF VICE PRESIDENT, MEDICAL & REGUALTORY AFFAIRS
CYTRX CORPORATION ANNOUNCES APPOINTMENT OF VICE PRESIDENT, HUMAN RESOURCES
CYTRX CORPORATION ANNOUNCES APPOINTMENT OF PRESIDENT AND CEO OF VAXCEL, INC.
CYTRX CORPORATION ANNOUNCES APPOINTMENT OF PRESIDENT AND CEO OF VAXCEL, INC.
CYTRX NAMES FRANCIS J. CASIERI TO HEAD EXPANDING OPERATIONS
CYTRX CORPORATION NAMES PRESIDENT AND CEO FOR VETLIFE INC.
VAXCEL ANNOUNCES NEW VICE PRESIDENT OF RESEARCH AND DEVELOPMENT
VETLIFE ANNOUNCES NEW VICE PRESIDENT OF RESEARCH AND DEVELOPMENT
CytRx to Present at IBC's Drug Discovery Technology 2004 Conference.
CytRx to Present at the 3rd International Metabolic Diseases Drug Discovery World Summit.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters